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ABSTRACT 
Purpose: To analyze conjunctival cytological features 1 month after pterygium 
excision using limbo-conjunctival autograft (LCA) with and without intraoperative 
mitomycin C and to assess tissue short-term evolution in both situations. 
Methods: Fifty-nine primary nasal pterygia from 59 patients were excised with 
LCA. Twenty-nine were treated with intraoperative mitomycin C 0.02% (MMC+) 
and thirty without it (MMC-). Impression cytology was performed in nasal and 
temporal conjunctiva before and one month after the excision. Goblet cells 
density (GCD) and nucleus-to-cytoplasm (N/C) non-goblet epithelial cell ratio 
were quantified. 
Results:  
Surgical strategy comparisons (Intergroup comparisons): All the preoperative 
data were, in mean, within the normal range, except for a slight goblet cell 
hyperplasia in the area of the lesion in MMC+ but no significant differences 
were found between the groups (p=0.079 for GCD and p=0.245 for N/C; 
ANOVA). Clinically relevant differences after surgery were only showed in nasal 
GCD that was significantly lower in MMC+ than in MMC- (p= 0.000; ANOVA) 
being the mean value in MMC+ slightly below normal values while in MMC- 
remained normal.  
Tissue evolution (Intragroup comparisons):No clinical relevant changes were 
found in MMC-. Data from MMC+ displayed no changes one month after 
surgery, except for nasal GCD that showed a significant reduction (p=0.000; 
paired t-test). Nevertheless, this GCD decrease was more modest than that 
previously described using mitomycin C without autograft, since in the present 
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study nasal GCD was not lower but similar to postoperative temporal data of the 
same eye (p=0.164; paired t test). 
Conclusions: LCA is a good technique for conjunctiva early recovery. When 
mitomycin C was added, the GCD reduction was lower than described using 
other surgical techniques. Mitomycin C, in optimal concentration and exposure, 
associated with LCA could be a good clinical option to minimize pterygium 
recurrence.  
 
Keywords: pterygium, impression cytology, mitomycin C, limbo-conjunctival 
autograft, goblet cells. 
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INTRODUCTION 
Pterygium is a common ocular surface disease characterized by the 
encroachment of a fleshy fibrovascular formation from the bulbar conjunctiva 
across the limbus, invading the cornea. Theories of pterygium pathogenesis 
have implicated ultraviolet light exposure as a major causative factor1,2 
Excessive exposure to UVB could damage limbal stem cells, leading to aberrant 
wound healing responses3. This wing-shaped lesion is often associated with 
inflammation, increased corneal astigmatism, obstructed vision, and 
unfavorable cosmetic effect4  
Different surgical techniques have been used to remove pterygium and prevent 
recurrence. Evidence indicates that bare sclera excision results in a significantly 
higher pterygium recurrence rate than excision accompanied by using certain 
adjuvants5,6, such as mitomycin C, and conjunctival (CA) or limbo-conjunctival 
autograft (LCA). Comparisons recently revealed that to use a combination of CA 
or LCA with mitomycin C could further reduce pterygium recurrence rate 
compared with a single adjuvant6. 
Mitomycin C is an antineoplastic-antibiotic agent produced by Streptomyces 
caespitosus that inhibits the synthesis of DNA, proteins and cellular RNA and is 
a potent inhibitor of fibroblasts proliferation. Drug use has improved not only 
recurrence rate after pterygium surgery but also the surgical results in other 
ocular disease, such as glaucoma, or corneal and conjunctival intraepithelial 
neoplasia7,8,9. 
Optimal mitomycin C concentration and exposure time have been analyzed to 
prevent its deleterious effects10,11,12,13 and single intraoperative low dose of the 
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drug is safer than postoperative topical daily application and it is effective 
reducing pterygium recurrence rates14,15.  
Delay in conjunctival epithelium healing could be early detected by impression 
cytology or in-vivo confocal microscopy when the chemoadjuvant was applied 
16,17. Important changes, mainly in goblet cell density, were found few weeks 
after surgery that lasted for long periods, even when mitomycin C was applied 
in optimal conditions. Nevertheless, tissue evolution after pterygium excision not 
only depends on mitomycin C use but other adjuvants seem to be determining 
factors in the process. In fact, autografting (with CA) seems to promote tissue 
healing compared to bare sclera or bare sclera with mitomycin C16. An optimal 
combination of adjuvants may be the key to reduce recurrences with early 
tissue recovery or, at least, with minimal alterations in short-term, suggesting a 
faster conjunctival recovery. However, to our knowledge, conjunctival epithelial 
phenotypes after LCA or combining LCA with mitomycin C have not been 
previously reported in short or long-term.  
The aim of this study is to compare conjunctival cytological features 1 month 
after pterygium excision using limbo-conjunctival autograft (LCA) with and 
without intraoperative mitomycin C and to assess tissue short-term evolution in 
both situations. Analysis of epithelial changes triggered by each specific 
adjuvant combination could improve the current risk/benefit knowledge of these 
strategies, and evidence-based decisions in pterygium clinical management.  
 
METHODS  
Fifty-nine eyes of 59 patients with primary nasal pterygium, 37 males and 22 
females, average age 43 ± 11.87, range 22-76 years, were enrolled in the 
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study. Patients with a history of ocular surgery, ocular trauma, contact lens 
wear, corneal scarring, pseudopterygia or anterior segment diseases, except for 
pterygium, were excluded from the study. Eyes were randomized into two 
groups according to the surgical technique used: LCA with mitomycin C 
(MMC+) and LCA without mitomycin C (MMC-). 
Before surgery, informed consent was obtained from each patient, and the 
study was carried out in accordance with the tenets of the Declaration of 
Helsinki and with the approval of the Ethics Committee of Consorci Sanitari de 
Terrassa Hospital de Terrassa (Barcelona, Spain). 
After topical and subconjunctival anesthesia, pterygium was removed, starting 
with a conjunctival incision on the body of the lesion using Westcott scissors 
(Miltex®). Tenon’s capsule tissue under the body of the pterygium was also 
removed. For the MMC+ group, when the excision was completed, regular-tip 
microsponges soaked with 0.025% mitomycin C solution (Mitomycin-C™Inibsa-
Hospital) were placed on the exposed sclera surface for 3 minutes and then 
removed. The exposed sclera was irrigated with 40 ml of balanced salt solution, 
and an LCA was obtained from the upper conjunctiva. The graft dissection was 
extended in all the lesions approximately 0.5 mm into the clear cornea to 
include the Vogt palisades and limbal stem cells and moved to cover the 
defective area. Then, it was secured with nylon sutures placing the limbal end of 
the autograft directly over the limbal area. All surgical procedures were 
performed by a single surgeon (P.P.). Damaged tissue was sent for pathological 
analysis. Postoperatively, patients were treated with topical tobramycin 3 mg/ml 
and dexamethasone 1mg/ml (Tobradex®; Alcon Cusi, S.A.Spain) tapered off in 
one month. Nylon sutures were removed at week 1. The clinical aspect of the 
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operated area was evaluated using fluorescein staining and slit-lamp 
examination one, 3, 6 and 12 months after pterygium excision and Prabhasawat 
criterion18 was applied to assess recurrence. Clinical adverse effects were also 
recorded.  
Before and one month after the surgery, impression cytology was performed by 
placing a triangular-shaped mixed cellulose ester filter paper (Millipore Biopore 
Membrane, code GSTFO1300; Millipore Corporation, BillericaMA) on the 
interpalpebral nasal and temporal conjunctiva. Filter paper were gently pressed 
on the ocular surface for 3-5 seconds and then removed. The samples were air-
dried for 1 min, fixed with 96% ethanol by immersion for at least 10 min and 
stained with periodic acid-Schiff–Gill’s modified Papanicolaou stain16. The 
specimens were examined by light microscopy and digitally recorded. Nucleus-
to-cytoplasm ratio (N/C) of 5-6 non-goblet epithelial cells were quantitatively 
assessed from 5 areas of each specimen using the Image J processing 
program (Rasband, National Institutes of Health, Bethesda, MD, 
http://rsb.info.nih.gov/ij/). The same process was performed to calculate goblet 
cell density (GCD, number of goblet cell/mm2). The averaged data were 
included in the statistical analysis as cytological variables. Healthy epithelial 
assessment was performed using Nelson and Wright criterion for N/C ratio19 
and Rivas and coworkers data for GCD in healthy conjunctival epithelium20. All 
the cytological measurements were made by the same practitioner (S.L.) who 
was unaware of the patient’s treatment. 
Statistical analysis 
After an exploratory data analysis, the variables were tested for normality by the 
Kolmogorov-Smirnov test. ANOVA was used to assess differences in the 
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cytological features between groups. Paired t test was applied to compare 
epithelial characteristics before and one month after surgery in temporal and 
nasal conjunctiva of each eye in MMC- , thus analyzing the recovery of the 
tissue. The same comparison was repeated in MMC+. This test was also 
applied to quantify alterations in GCD postoperative topographical distribution, 
comparing nasal with temporal data of the same eye. A p value of <0.05 was 
considered statistically significant. Statistical analysis was performed using 
SPSS V19 (SPSS Inc, Chicago, Illinois). 
 
RESULTS  
Twenty-nine eyes were included in MMC+ and 30 in MMC-. All were classified 
as grade 1 of Prabhasawat one month after the surgery, when impression 
cytology was performed. None of the eyes presented mitomycin C clinical 
adverse reactions during the 12 months follow-up period. Nevertheless, 4 eyes 
(13%) in MMC- and 1 eye (3%) in MMC+ disclosed recurrence at 12 months. 
The summary statistic of the cytological variables pre and postoperatively (1 
month after surgery) are presented in table 1 (temporal and nasal data of 
MMC+) and table 2 (temporal and nasal data of MMC-).  
 
Preoperative comparison between MMC+ and MMC- 
All the preoperative data were, in mean, within the normal range, except for a 
slight goblet cell hyperplasia in the area of the lesion in MMC+. Nevertheless, 
statistical comparison between the two groups displayed no significant 
differences in all the initial cytological features (p=0.079 for GCD and p=0.245 
for N/C; ANOVA).  
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Postoperative comparison between MMC+ and MMC- 
One month after surgery, N/C were significantly higher in MMC+ than in MMC- 
in both temporal and nasal zones (p=0.000 and p=0.007, respectively; ANOVA) 
but the mean exhibited normal values for both groups in all the studied 
locations. Nasal GCD was significantly lower in MMC+ than in MMC- (p= 0.000; 
ANOVA). This difference was clinically relevant since the mean value in MMC+ 
was slightly below normal values while in MMC- remained normal.  
 
Conjunctival short-term evolution. Postoperative vs preoperative 
cytological features 
Paired t test was applied comparing cytological characteristics before and 1 
month after pterygium excision in MMC- and the analysis was repeated for 
MMC+.  
Among the studied variables and locations in MMC-, only temporal N/C showed 
a slightly reduction (p<0.001; paired t-test) but the mean remained within 
normal values, as we have commented before. In MMC+, temporal conjunctiva 
displayed no significant modifications and nasal conjunctiva showed similar N/C 
ratio but a GCD significant reduction (p=0.000; paired t-test) of 272.69 
cells/mm2, in average, (95% confidence interval of the mean difference between 
151 and 393 cells/mm2), thus leading to an abnormal mean, as mentioned 
above. 
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Conjunctival short-term evolution. Postoperative Comparison between 
temporal and nasal conjunctiva  
In order to quantify altered topographical distribution of GCD and subsequently 
to contrast our results with other previous described in the literature, 
comparisons between nasal and temporal conjunctiva in MMC- , one month 
after surgery, were carried out and the same analysis was repeated for MMC+. 
A greater GCD in nasal than temporal area was found in MMC- (p=0.000; 
paired t test) with a mean difference of 125 cells/mm2 (95% confidence interval 
between 87 and 161cells/mm2). This difference is a distinctive feature of healthy 
conjunctiva20. However, postoperative nasal GCD data in MMC+ were similar to 
temporal data, (p=0.164; paired t test). Although this result was indicative of an 
abnormal topographical distribution, the data revealed a clearly milder GCD 
reduction in the injured area than that previously described using mitomycin C 
without autograft, as is discussed in the next section.  
 
DISCUSSION 
The findings of this study demonstrate that conjunctival epithelium has already 
recovered its normal characteristics one month after nasal pterygium excision 
with LCA. When combined LCA with mitomycin C, a significant reduction of 
nasal GCD was observed while the rest of cytological features remained normal 
in the two studied zones one month after surgery. Postoperative nasal and 
temporal GCD were similar in MMC+. Hence, changes in topographical 
distribution produced by mitomycin C could be considered as relatively modest 
when LCA was used.  
11 
 
Preoperative MMC+ mean values showed a slight goblet cell hyperplasia in the 
area of the lesion, which is consistent with previous reports about epithelial 
phenotype of pterygium16,21 but was not disclosed in preoperative MMC- mean 
values of the same zone. By contrast, the more definitive results of ANOVA 
displayed no statistical differences in initial conditions between the two groups. 
Actually, goblet cell density has always shown a high variability in both healthy 
epithelial conjunctiva20,22 and pterygium lesion16,21,23,24 and seems to be closely 
linked with tear osmolarity and ocular surface inflammation25,26 both conditions 
related with pterygium4,27. This complex interaction would be the cause of the 
high variability observed in the studies and could explain the more apparent 
than real differences in GCD between the groups before the surgery. 
Non secretory cells of conjunctival epithelium retained their normal phenotype 
one month after surgery in both surgical strategies and did not show squamous 
metaplasia, usually associated with keratoconjunctivitis sicca and different 
cicatrizing diseases and ocular irritation disorders28,29. In fact, this is an 
expected result since none of the surgical techniques, which were used before, 
seems to trigger this kind of tissue alteration16,23,30. However, squamous 
metaplasia was reported in conjunctival epithelium when mitomycin C drops 
were used in an intensive topical treatment for primary acquired melanosis with 
atypia31. In the other hand, slight scamous metaplasia has been recently 
described in 31.3% of the samples (16 eyes) from the pterygium side, 6 months 
after excision with limbal autograft without mitomycin C32. Authors suggested 
that it might be related to recurrence. 
Eyes with LCA without mitomycin C showed the same conjunctival phenotype 1 
month after than before the surgery confirming this surgical strategy as a good 
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solution for a rapid epithelial recovery. Autograft promotion of conjunctival 
healing may be slower using CA than LCA since 6 months were necessary to 
achieve similar cytological results than in fellow control eyes16. Further 
comparative studies, applying the same design, are necessary to clarify this 
question, investigating the limbal postoperative condition with a confocal 
microscopy analysis.  
Despite certain risk of limbal damage at the donor site of the graft33, LCA is one 
of the best choices for pterygium management5,6. It is safe, with acceptable 
recurrence rate, and could be more effective than CA in prevent regrown of 
recurrent pterygia34. Nevertheless, as we have commented in the introduction 
section, using a combination of conjunctival or limbal autograft with mitomycin C 
further reduces the recurrence rate compared with conjunctival or limbal 
autograft or mitomycin C alone6.  
Eyes with LCA and mitomycin C showed a reduction in nasal GCD that led to 
abnormal results in this zone. GCD decrease has been also described in 
previous cytological assessments after bare sclera excision with intraoperative 
mitomycin C16,23,30. The drug seems to delay GCD recovery regardless of the 
surgical technique chosen. However, this choice could determine cell loss 
magnitude and duration. Indeed, GCD decrease produced by mitomycin C 
combined with bare sclera excision seems to be more severe and prolonged 
than that triggered by the combination of the drug with LCA. Solomon and co-
workers30 reported a 4-fold decrease at the excision area (nasal) when 
compared with the contralateral nonoperated side (temporal) at a mean of 77.2 
months after the surgery (range, 72-84 months after surgery). Far from it, in our 
study GCD maintained similar values in nasal than temporal side 1 month after 
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pterygium excision. These differences are plausible since autograft (using CA) 
has been described as a clear promoter of conjunctival healing in pterygium 
excision16. This quality may be due to the presence of graft basement 
membrane that serves as a substrate for the regenerating epithelium16,18. LCA 
and mitomicyn C combination with a careful patient selection could be a good 
choice for pterygium management in terms of risk/benefit ratio. The present 
study provides evidence in this sense. This adjuvant combination not only 
seems to minimize drug toxicity but reduce the percentage of recurrence. 
Nevertheless, further assessments with large samples are necessary to ratify 
this therapeutic issue.  
In conclusion, pterygium excision with LCA seems to be an adequate technique 
to achieve a rapid conjunctival recovery and could minimize goblet cell 
alteration when mitomycin C was added to further reduce recurrences. The 
more modest drug epithelial toxicity one month after application clearly 
evidences the protective value of LCA. Mitomycin C, in optimal concentration 
and exposure, associated with LCA could be a good clinical option to minimize 
pterygium recurrence.  
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Figure 1 
Examples of impression cytology in MMC- (images A and B) and in MMC+ 
(images C and D), before (left) and after (right) lesion excision. Periodic acid-
Schiff–Gill’s modified Papanicolaou stain. 
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Table 1.Summary statistics of the cytological variables pre and postoperatively 
in MMC+ group. 
 
  N (MMC+)  T (MMC+) 
  Preoperatively Postoperatively Preoperatively Postoperatively 
Variable GCD N/C GCD N/C GCD N/C GCD N/C 
Average 385 0.6 113 0.6 112 0.6 126 0.7 
Median 351 0.6 103 0.6 99 0.6 93 0.7 
S.D. 259 0.2 113 0.2 85 0.2 89 0.2 
Minimun 18 0.2 4 0.4 5 0.3 28 0.1 
Maximun 1019 1.0 554 1.0 318 1.0 381 1.0 
 
GCD (goblet cell density), N/C (nucleus-to-cytoplasm ratio). Nasal GCD normal 
range.20= 159-323 cells/mm2. Temporal GCD normal range20= 65-265 
cells/mm2.Normal ratio N/C19 ≥0.5 
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Table 2.Summary statistics of the cytological variables pre and postoperatively 
in MMC- group. 
 
  N (MMC-)  T (MMC-) 
  Preoperatively Postoperatively Preoperatively Postoperatively 
Variable GCD N/C GCD N/C GCD N/C GCD N/C 
Average 229 0.5 213 0.5 106 0.6 86 0.5 
Median 192 0.5 225 0.5 87 0.6 69 0.5 
S.D. 184 0.1 74 0.1 59 0.1 63 0.1 
Minimun 40 0.3 53 0.3 43 0.4 10 0.4 
Maximun 773 0.7 329 0.8 310 1.1 298 1.0 
GCD (goblet cell density), N/C (nucleus-to-cytoplasm ratio). Nasal GCD normal 
range.20= 159-323 cells/mm2. Temporal GCD normal range.20= 65-265 
cells/mm2.Normal ratio N/C19 ≥0.5 
 
 
 
